Picture of SpectraCure AB (publ) logo

SPEC — SpectraCure AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Spectracure Gets Approval To Commence Clinical Trial

Oct 8 (Reuters) - SpectraCure AB (publ) SPEC.ST:

RECEIVES FINAL APPROVAL FROM GERMAN  AUTHORITIES TO COMMENCE CLINICAL TRIAL

Source text: ID:nMFN2d6bpq

Further company coverage: SPEC.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on SpectraCure AB (publ)

See all news